Aditxt, Inc. Debt Instrument, Interest Rate, Effective Percentage
Aditxt, Inc. (ADTX) had Debt Instrument, Interest Rate, Effective Percentage of 8.25% as of 2023-06-12, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2023-08-14
- 2023-06-12: Debt Instrument, Interest Rate, Effective Percentage 8.25%.
- 2023-05-25: Debt Instrument, Interest Rate, Effective Percentage 8.25%.
- 2023-04-21: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2022-07-21: Debt Instrument, Interest Rate, Effective Percentage 4.75%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2023-06-12 | 8.25% 10-Q · filed 2023-08-14 |
| 2023-05-25 | 8.25% 10-Q · filed 2023-08-14 |
| 2023-04-21 | 8.00% 10-Q · filed 2023-08-14 |
| 2022-07-21 | 4.75% 10-K · filed 2023-04-17 |
| 2021-12-31 | 8.00% 10-K · filed 2022-03-31 |
| 2021-09-30 | 8.00% 10-Q · filed 2021-11-15 |
| 2021-02-28 | 8.00% 10-Q · filed 2021-08-12 |
| 2020-11-30 | 8.00% 10-Q · filed 2021-05-12 |
| 2020-10-31 | 8.00% 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |